Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

Launched on May 1, 2006, the iShares U.S. Healthcare Providers ETF (IHF) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Healthcare - Providers segment of the equity market.

Zacks Investment Research • Oct 20, 2025

IHF: Attractive U.S. Healthcare Valuations Amid Sector's Recovery

I rate IHF a buy due to its concentration in large-cap healthcare leaders, attractive valuation, and recent price dip offering a compelling entry point. The fund is well-positioned to benefit from demographic shifts and AI-driven innovation, capturing growth in managed care and healthcare services. Risks include high concentration in top holdings, regulatory scrutiny, rising costs, and macroeconomic uncertainty that could pressure margins and valuations.

Seeking Alpha • Aug 16, 2025

5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New Highs

The Big Beautiful Bill boosts defense, industrials, and manufacturing, but healthcare and some REITs face headwinds from Medicaid cuts and policy shifts. AI optimism and the new legislation are fueling a broad market rally, but I question if AI stocks are outpacing their earnings, signaling a potential bubble. The Magnificent 7 era is over; META, MSFT, NVDA, and AMZN are the new leaders, while AAPL, GOOG, and TSLA face unique challenges in the AI race.

Seeking Alpha • Jul 5, 2025

IHF: Clouds Linger Over Healthcare Providers

iShares U.S. Healthcare Providers ETF faces operational uncertainty and poor momentum, due to sector headwinds and UNH's troubles, justifying my hold rating. Valuation is attractive with a low P/E and PEG ratio, but significant bad news is already priced in, limiting downside conviction. Portfolio concentration in top holdings and low dividend yield make IHF risky and unattractive for income-focused investors.

Seeking Alpha • Jun 4, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

6 ETFs Showing Great Resilience Amid Market Sell-Offs

U.S. stocks have been witnessing massive sell-offs this month due to trade tensions. However, these ETFs survived the bloodbath.

Zacks Investment Research • Apr 11, 2025

Diagnosing the Market on Health Day: 6 ETFs Looking Healthy

Following the worst week since the start of the pandemic, let's examine the health of the U.S. stock market on World Health Day.

Zacks Investment Research • Apr 7, 2025

5 ETFs Withstanding the Biggest Market Drop Since 2020

The major U.S. indices log their biggest one-day slide in five years. Here are five ETFs that succeeded in withstanding the turmoil.

Zacks Investment Research • Apr 4, 2025

IHF: Healthcare Dashboard For March

This article provides a top-down analysis of the healthcare sector, using key industry metrics. The healthcare equipment industry offers the best combination of value and quality scores, whereas pharmaceuticals/biotechnology is the most overvalued subsector. iShares U.S. Healthcare Providers ETF is highly concentrated and has underperformed the sector benchmark XLV since 2006, making it less appealing for long-term investment.

Seeking Alpha • Mar 19, 2025